866-997-4948(US-Canada Toll Free)

Published on : Sep 20, 2019

The global ceramides market is likely to surge during 2019 to 2029 at robust rate, reveals a report by Researchmoz. 

The demand for ceramides is ever growing due to its wide applicability. The growing beauty and cosmetics industry is anticipated to push the global ceramides market to expand in the upcoming years. It is used in products such as anti-aging creams, moisturizing lotion, etc. 

Pharmaceutical Sector to Boost Ceramides Market 

Some forms of presence of lipid in ceramides help in boosting metabolic physiology. It can help with insulin resistance and apoptosis. This may lead aid in the growth of the global ceramides market

Ceramides act as a skin barrier and prevents skin inflammation and they are used in used in treatment of psoriasis and atopic dermatitis. This allows the skin to retain moisture, thus prevents the skin from drying and associated skin problems. These factors of ceramides are projected to drive the global ceramides market to expand in future. 

Futher, ceramides have been proposed as biomarker for many treatment therapies such as reducing apoptsis, heart shock, insulin resistance, cooronry artery diseases, and alzheimer’s disease. This is likely to nudge the growth in the global ceramides market in the upcoming years. 

Plant based ceramides are also gaining popularity over the last few years due to growing trend of demand for clean labeled products. This might contribute in the expansion of the global ceramides market. 

Request a Sample PDF copy with detailed Insights: https://www.researchmoz.us/enquiry.php?type=S&repid=2322639

Asia Pacific to Lead Ceramides Market 

The Asia pacific is anticipated to witness the growth in the global ceramides market. The growth can be due to increasing awareness about wide range of cosmetics and beauty products are prognosticated to drive the global ceramides market. 

North America is also expected to contribute in expansion of the global ceramides market due the better medical and pharmaceutical infrastructure.